YSS · York Space Systems Inc.

Current Thesis

York Space Systems’ procurement-delay recovery case has failed its published price test; rebuilding it requires funded orders, renewed backlog growth and recovery of the lost $8.86 shelf. The 2026-09-11 adjusted weekly close of $7.88 breached the invalidation retained in the 2026-08-30 dossier. That closes the prior reset thesis as invalidated; the available evidence does not establish a replacement support level.

The narrative is dead — the 2026-08-13 revenue-guidance reduction and the subsequent breach of $8.86 outweigh the August programme selections in this assessment. The remaining fundamental proposition is management’s explanation that government procurement changes deferred revenue. York’s August results described a shift toward indefinite-delivery, indefinite-quantity (IDIQ) contracts and reduced full-year 2026 revenue guidance to $375–405 million from $545–595 million. Whether funded orders restore backlog is the observable test of that explanation. York’s August 13 results.

The legal evidence has also advanced beyond the prior note’s investigation notices. On 2026-09-10, Bernstein Liebhard stated that a securities class action had been filed and identified a 2026-10-30 lead-plaintiff deadline. This is an attributed report of litigation, not a finding that the allegations are true; the announcement does not provide a court docket identifier. Bernstein Liebhard announcement.

Bullish and bearish views on York Space Systems Inc.

The model's bull view on York Space Systems Inc. (YSS), in brief: Delivery provides operating evidence. York’s 2026-08-25 announcement reported all 42 company-built Space Development Agency Tranche 1 Transport Layer satellites launched and healthy in orbit. This supports completed delivery capability; it does not establish the value or timing… The bear view: The published shelf has failed. The 2026-09-11 adjusted weekly close of $7.88 was below the dossier’s $8.86 invalidation. The three-month price change was −71.5%; the prior recovery case cannot be described as intact. Backlog was already contracting. York reported backlog of… Both cases follow in full.

Bull Case

• Delivery provides operating evidence. York’s 2026-08-25 announcement reported all 42 company-built Space Development Agency Tranche 1 Transport Layer satellites launched and healthy in orbit. This supports completed delivery capability; it does not establish the value or timing of replacement orders.
• Cash supports the reset argument. The reported 2026-06-30 balance sheet contained $534 million of cash and equivalents, while backlog stood at $592.0 million. These are dated financial resources and contracted work, not evidence that the September valuation decline has ended.
• Margins improved despite the reduction. York’s 2026-08-13 release reported second-quarter gross margin of 24%, compared with 11% a year earlier, and gross profit of $22.2 million against $9.5 million. That is measured operating improvement alongside the reduced annual revenue outlook. Company results.

Bear Case

• The published shelf has failed. The 2026-09-11 adjusted weekly close of $7.88 was below the dossier’s $8.86 invalidation. The three-month price change was −71.5%; the prior recovery case cannot be described as intact.
• Backlog was already contracting. York reported backlog of $592.0 million at 2026-06-30, down 8% quarter over quarter. A further decline in the next quarterly report would contradict the proposed backlog recovery.
• Programme access is incomplete evidence. The 2026-08-18 NITE-STAR selection granted eligibility to compete for task orders. Air & Space Forces Magazine’s 2026-08-25 reporting described York’s Space Data Network Backbone award as a $12 million demonstration contract; neither observation establishes recovery to the former annual revenue guidance.
• Litigation reporting has escalated. Bernstein Liebhard’s 2026-09-10 notice describes a filed securities class action, superseding the prior note’s investigation-only framing. The notice supplies allegations rather than an adjudicated conclusion. Law-firm announcement.

Setup & Price Structure

The supplied adjusted series records a $7.88 close and a 14-day relative strength index (RSI) of 33.8 on 2026-09-11. The $8.86 post-guidance-cut shelf remains the historical thesis boundary. The latest close is a reference observation, not a newly demonstrated floor. No moving-average series or trading-volume history is supplied, so neither distance above a rising average nor accumulation can be established.

The observable coverage cluster consists of JPMorgan’s 2026-08-17 downgrade, Canaccord Genuity’s 2026-08-18 downgrade, and target reductions from Jefferies on 2026-08-18 and Truist on 2026-08-20. These are analyst actions, not measurements of investor positioning. Current short interest, borrow costs, retail participation and verified insider transactions are missing; the available coverage does not support a crowding conclusion.

York announced on 2026-08-27 that its chief executive was scheduled to present at the Jefferies Global Industrials Conference on 2026-09-09. That scheduled date has passed. The subsequent September 11 close remained below the published shelf, but the chronology alone does not establish the presentation’s effect on price. Company conference announcement.

Catalyst Calendar (next 30 days)

• 2026-09-30 — federal fiscal year-end. This is a procurement observation date, not a York commitment to announce an award. A disclosed funded task order would provide evidence relevant to management’s 2026-08-13 procurement-delay explanation. Silence would leave that explanation unconfirmed; it would not independently prove permanent demand loss.

No company-confirmed catalyst date was established for 2026-09-13 through 2026-10-13. The retrieved company event calendar does not establish the next quarterly reporting date, so an earnings date is not presented as confirmed. York events calendar.

What Would Change Our Mind

The lost post-guidance-cut shelf has already broken the prior case: a weekly close below $8.86 occurred on 2026-09-11 at $7.88. Retaining that boundary preserves the published outcome instead of substituting a lower threshold after failure.

Evidence for a separate recovery thesis would require a weekly close above $8.86 together with disclosed funded orders and backlog growth above the reported 2026-06-30 balance of $592.0 million. Those conditions would justify reassessment, not reverse the recorded invalidation. Another backlog decline or a reduction below the 2026-08-13 revenue-guidance range of $375–405 million would contradict the fundamental recovery proposition.

Correlation Notes

This remains a single-name assessment. The 2026-08-25 Space Data Network Backbone reporting places York alongside other contractors, establishing shared procurement exposure rather than measured share-price correlation. No paired return series is supplied for York and its peers, so the evidence cannot establish whether a broader space-equity move explains the 2026-09-11 three-month decline of 71.5%. A group recovery is not part of the published case.